2023-04-12
Development progress | Class I innovative drug RSV vaccine IND application accepted by CDE
The application for a new drug clinical trial (IND) of recombinant respiratory syncytial virus (RSV) vaccine (CHO cells) independently developed and jointly applied by a wholly-owned subsidiary has been officially accepted by the Drug Evaluation Center (CDE) of the National Medical Products Administration (Acceptance Number: CXSL2400228).



————
The scale of the main adjuvant varieties meets the dosage of one million doses of vaccine/batch, and has been applied to the development of multiple vaccine varieties.
With over 20 years of experience in industrial research and development of glycochemistry, based on the technology of complex glycochemistry synthesis and quality analysis platform, we have designed and synthesized over 20 new immune adjuvant molecules in six categories, including TLR3 (dsRNA), TLR4 (monophosphate lipid A), TLR7/8, TLR9 (oligonucleotides), saponins, and NKT agonists, against new adjuvant varieties approved by the FDA.
20Years+ 100Doses of vaccine/Batch 20Type+
Research experience in glycochemistry Meet the scale of usage Six categories of new adjuvants

  • Innovation Platform
  • Research Achievements
  • R&D Pipeline
  • Recombinant protein platform
    Recombinant protein platform
    Using genetic engineering technology to quickly identify potential antigens and modify their genes to enhance their immunogenicity and integrate them into appropriate expression systems
  • Adjuvant technology platform
    Adjuvant technology platform
    We have nearly 20 types of adjuvant raw materials, achieve independent design and production, control costs and quality, break away from dependence on raw material imports, and have reached the forefront of global quantity.
  • MRNA technology platform
    MRNA technology platform
    MRNA technology can achieve the integration of nucleic acid and delivery, and Maikekang Biotechnology has established an mRNA platform with non replicative mRNA technology
Phone
+86-21-68403318
QQ
1905311766
WeChet
WeChet
Scan Code
On-Line
Submit